Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-03-17 to 2022-03-28
Current total value of award: $742.4
Description: 8508950275!CLONAZEPAM TABLETS